EFG
REGN icon

Everhart Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Everhart Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$338K Sell
542
-118
-18% -$80.3K 0.02% 341
2026
Q1 		$510K Buy
660
+200
+43% +$153K 0.04% 272
2025
Q4 		$355K Buy
460
+83
+22% +$56.4K 0.03% 301
2025
Q3 		$212K Buy
+377
New +$213K 0.02% 371
2025
Q2 		– Sell
-512
Closed -$325K – 352
2025
Q1 		$325K Buy
512
+160
+45% +$110K 0.04% 270
2024
Q4 		$251K Sell
352
-508
-59% -$426K 0.05% 278
2024
Q3 		$904K Buy
860
+310
+56% +$345K 0.2% 112
2024
Q2 		$578K Buy
550
+71
+15% +$68.8K 0.15% 141
2024
Q1 		$461K Buy
479
+68
+17% +$64.7K 0.13% 158
2023
Q4 		$361K Buy
411
+23
+6% +$18.9K 0.13% 151
2023
Q3 		$319K Buy
388
+45
+13% +$35.4K 0.14% 148
2023
Q2 		$246K Buy
343
+23
+7% +$17.7K 0.1% 177
2023
Q1 		$263K Buy
320
+40
+14% +$30.2K 0.12% 158
2022
Q4 		$202K Sell
280
-104
-27% -$76.7K 0.1% 174
2022
Q3 		$264K Buy
+384
New +$242K 0.15% 144

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
HCM
Howland Capital Management Boston, Massachusetts $2.77B AUM 19.56% 1-Year Est. Return

Everhart Financial Group's REGN Position: Q2 2026 in Review

Everhart Financial Group reduced its Regeneron Pharmaceuticals (REGN) stake by 18% in Q2 2026, selling an estimated $80.3K and leaving 542 shares worth $338K. The position accounts for 0.02% of the portfolio, ranked #341.

Everhart Financial Group first reported a position in REGN in Q3 2022 and has held it in 15 quarters since. The position peaked at $904K in Q3 2024. 262 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Everhart Financial Group held 542 shares of Regeneron Pharmaceuticals worth $338K as of Q2 2026.
  • Everhart Financial Group sold 118 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $80.3K.
  • Regeneron Pharmaceuticals made up 0.02% of Everhart Financial Group's portfolio in Q2 2026, its #341 holding.
  • Everhart Financial Group first reported a position in Regeneron Pharmaceuticals in Q3 2022 and has held it in 15 quarters since.
  • Everhart Financial Group's Regeneron Pharmaceuticals position peaked at $904K in Q3 2024.
  • 262 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.